ArticleFrontiers in immunology2018

LIGHT/TNFSF14 as a New Biomarker of Bone Disease in Multiple Myeloma Patients Experiencing Therapeutic Regimens.

Giacomina Brunetti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.